- Over 80% of patients progression free at 9 months in the first-line treatment of advanced non-small cell lung cancer CHICAGO , May 31, 2015... ...http://in.advfn.com/p.php?pid=nmona&article=67084980
PR.com 2015-05-30 Burton-on-Trent, United Kingdom, May 30, 2015 --( PR.com )-- Clinigen Group plc (Clinigen, AIM: CLIN) today announce the... ...http://www.bizwireexpress.com/showstoryPRcom.php?storyid=376362
The company has recently cut the maximum retail price of its three lung cancer drugs Erleva (erlotinib), Geftib (gefitinib) and Pexotra... ...http://www.dnaindia.com/money/report-glenmark-cuts-lung-cancer-drug-price-2089524
AstraZeneca and MedImmune, the company's global biologics research and development arm, will demonstrate rapid progress with their... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=88266&sid=2
Comments GENEVA, April 17, 2015 /PRNewswire/ -- ASSESS shows plasma circulating tumour DNA (ctDNA) testing for EGFR mutation is a viable... ...http://www.andhranews.net/Intl/Web/62-50.asp
Buy Gefitinib 250mg Tablets Online
Buy Gefitinib Iressa 250mg Tablets...
Gefitinib, Erlonat, Veenat, Sorafenib.
Pharma Exporter & Bulk Wholesale...